REG1VN0126.HE Revenio Group Oyj

- EUR
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Is REG1VN0126.HE undervalued?

Graham number

The Graham number of Revenio Group Oyj cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Revenio Group Oyj fundamental analysis

No fundamental analysis for Revenio Group Oyj yet.

Revenio Group Oyj stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Sensors that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or eme…

Full company profile